Carisbamate is an organochlorine compound. Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence. CARISBAMATE is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications. Its therapeutic use is listed as anticonvulsants. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Comfyde and carisbamato. Its PubChem CID is 6918474.
Carisbamate
| CAS No | 194085-75-1 |
|---|---|
| Molecular Formula | C9H10ClNO3 |
| Molecular Weight | 215.63 g/mol |
| Synonyms | [(2S)-2-(2-chlorophenyl)-2-hydroxyethyl] carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Carisbamate is an organochlorine compound. Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence. CARISBAMATE is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications.
The listed CAS number is 194085-75-1.
The listed molecular formula is C9H10ClNO3.
The listed molecular weight is 215.63 g/mol.
[(2S)-2-(2-chlorophenyl)-2-hydroxyethyl] carbamate.
The source lists Comfyde and carisbamato.